Neuropathological spectrum of synucleinopathies - PubMed (original) (raw)
Review
. 2003 Sep:18 Suppl 6:S2-12.
doi: 10.1002/mds.10557.
Affiliations
- PMID: 14502650
- DOI: 10.1002/mds.10557
Review
Neuropathological spectrum of synucleinopathies
Kurt A Jellinger. Mov Disord. 2003 Sep.
Abstract
Synucleinopathies comprise a diverse group of neurodegenerative proteinopathies that share common pathological lesions composed of aggregates of conformational and posttranslational modifications of alpha-synuclein in selected populations of neurons and glia. Abnormal filamentous aggregates of misfolded alpha-synuclein protein are the major components of Lewy bodies, dystrophic (Lewy) neurites, and the Papp-Lantos filaments in oligodendroglia and neurons in multiple system atrophy linked to degeneration of affected brain regions. The synucleinopathies include (1) Lewy body disorders and dementia with Lewy bodies, (2) multiple system atrophy (MSA), and (3) Hallervorden-Spatz disease. (1) The pathological diagnosis of Lewy body disorders and dementia with Lewy bodies is established by validated consensus criteria based on semiquantitative assessment of subcortical and cortical Lewy bodies as their common hallmarks. They are accompanied by subcortical multisystem degeneration with neuronal loss and gliosis with or without Alzheimer pathologic state. Lewy bodies also occur in numerous other disorders, including pure autonomic failure, neuroaxonal dystrophies, and various amyloidoses and tauopathies. (2) Multiple system atrophy, a sporadic, adult-onset degenerative movement disorder of unknown cause, is characterized by alpha-synuclein-positive glial cytoplasmic and rare neuronal inclusions throughout the central nervous system associated with striatonigral degeneration, olivopontocerebellar atrophy, and involvement of medullar and spinal autonomic nuclei. (3) In neurodegeneration with brain iron accumulation type I, or Hallervorden-Spatz disease, alpha-synuclein is present in axonal spheroids and glial and neuronal inclusions. While the identity of the major components of Lewy bodies suggests that a pathway leading from normal soluble to abnormal misfolded filamentous proteins is central for their pathogenesis, regardless of the primary disorder, there are conformational differences in alpha-synuclein between neuronal and glial aggregates, showing nonuniform mapping for its epitopes. Despite several cellular and transgenic models, it is not clear whether inclusion body formation is an adaptive/neuroprotective or a pathogenic reaction/process generated in response to different, mostly undetermined, functional triggers linked to neurodegeneration.
Copyright 2003 Movement Disorder Society
Similar articles
- Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E, Gonzalo I, Newell K, García Yébenes J, Vonsattel P, Hyman BT. Gómez-Tortosa E, et al. Acta Neuropathol. 2002 May;103(5):495-500. doi: 10.1007/s00401-001-0495-3. Epub 2002 Feb 23. Acta Neuropathol. 2002. PMID: 11935266 - Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T. Sasaki K, et al. Acta Neuropathol. 2002 Sep;104(3):225-30. doi: 10.1007/s00401-002-0546-4. Epub 2002 May 9. Acta Neuropathol. 2002. PMID: 12172907 - Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M. Goedert M. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1101-18. doi: 10.1098/rstb.1999.0466. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434313 Free PMC article. Review. - Clinical overview of the synucleinopathies.
Martí MJ, Tolosa E, Campdelacreu J. Martí MJ, et al. Mov Disord. 2003 Sep;18 Suppl 6:S21-7. doi: 10.1002/mds.10559. Mov Disord. 2003. PMID: 14502652 Review. - [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T. Iwatsubo T. Rinsho Shinkeigaku. 1999 Dec;39(12):1285-6. Rinsho Shinkeigaku. 1999. PMID: 10791099 Japanese.
Cited by
- Anti-MAG autoantibodies are increased in Parkinson's disease but not in atypical parkinsonism.
Papuć E, Rejdak K. Papuć E, et al. J Neural Transm (Vienna). 2017 Feb;124(2):209-216. doi: 10.1007/s00702-016-1632-4. Epub 2016 Oct 20. J Neural Transm (Vienna). 2017. PMID: 27766424 - "Janus-Faced" α-Synuclein: Role in Parkinson's Disease.
Ray B, Mahalakshmi AM, Tuladhar S, Bhat A, Srinivasan A, Pellegrino C, Kannan A, Bolla SR, Chidambaram SB, Sakharkar MK. Ray B, et al. Front Cell Dev Biol. 2021 May 28;9:673395. doi: 10.3389/fcell.2021.673395. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34124057 Free PMC article. Review. - Alpha-Synuclein in Skin Nerve Fibers as a Biomarker for Alpha-Synucleinopathies.
Kim JY, Illigens BM, McCormick MP, Wang N, Gibbons CH. Kim JY, et al. J Clin Neurol. 2019 Apr;15(2):135-142. doi: 10.3988/jcn.2019.15.2.135. J Clin Neurol. 2019. PMID: 30938106 Free PMC article. Review. - Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration.
Gerard M, Deleersnijder A, Demeulemeester J, Debyser Z, Baekelandt V. Gerard M, et al. Mol Neurobiol. 2011 Aug;44(1):13-27. doi: 10.1007/s12035-011-8184-2. Epub 2011 May 7. Mol Neurobiol. 2011. PMID: 21553017 Review. - Survival in synucleinopathies: A prospective cohort study.
Goldstein DS, Holmes C, Sharabi Y, Wu T. Goldstein DS, et al. Neurology. 2015 Nov 3;85(18):1554-61. doi: 10.1212/WNL.0000000000002086. Epub 2015 Oct 2. Neurology. 2015. PMID: 26432848 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous